Skip to main content
main-content

25-09-2017 | Urothelial cancer | ESMO 2017 | Video

ESMO 2017: RANGE trial results

Daniel Petrylak outlines the RANGE trial results for use of ramucirumab in patients with advanced urothelial carcinoma. 

2021 Genitourinary Cancers Symposium

View our abstract recommendations for the upcoming virtual meeting

Image Credits